Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Takashi, ICHIMURA"'
Autor:
Akira Ooki, Taroh Satoh, Kei Muro, Atsuo Takashima, Shigenori Kadowaki, Daisuke Sakai, Takashi Ichimura, Seiichiro Mitani, Toshihiro Kudo, Keisho Chin, Shigehisa Kitano, Dung Thai, Marianna Zavodovskaya, JieJane Liu, Narikazu Boku, Kensei Yamaguchi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Andecaliximab (ADX) is a monoclonal antibody that inhibits matrix metalloproteinase 9 (MMP9), an extracellular enzyme involved in matrix remodeling, tumor growth, and metastasis. In preclinical models, MMP9 inhibitors have been shown to enha
Externí odkaz:
https://doaj.org/article/47b63337491a4ba288e5e4723a34c5c6
Autor:
Atsuo Takashima, Narikazu Boku, Taroh Satoh, Shigenori Kadowaki, Kei Muro, Shigehisa Kitano, Kensei Yamaguchi, Keisho Chin, Marianna Zavodovskaya, Dung Thai, Akie Kimura Yoshikawa, Takashi Ichimura, Daisuke Sakai, Toshihiro Kudo, Seiichiro Mitani, JieJane Liu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/7cc785fafdf148689d07c0a9e332c912
Autor:
Yuta Ushida, Eiji Shinozaki, Keisho Chin, Mitsukuni Suenaga, Daisuke Takahari, Masato Ozaka, Mariko Ogura, Takashi Ichimura, Takeru Wakatsuki, Kensei Yamaguchi
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 2, Pp 601-608 (2018)
Background: Colorectal cancer (CRC) with lung metastases has an unfavorable prognosis. However, nowadays, even advanced CRC can have a favorable outcome in certain cases. A complete response (CR) is a rare event in advanced CRC with lung metastases.
Externí odkaz:
https://doaj.org/article/de2e4de53b094e818ba71695fdf17ada
Autor:
Koki Hashimoto, Erika Sugiyama, Mitsukuni Suenaga, Kazuyoshi Kawakami, Hiyori Kidokoro, Takeru Wakatsuki, Masataka Tajima, Keisho Chin, Eiji Shinozaki, Hitoshi Sato, Takashi Ichimura, Yuichi Minowa, Wataru Suzuki, Yasuhiro Nakano, Izuma Nakayama, Kazuo Kobayashi, Mariko Ogura, Toshihiro Hama, Daisuke Takahari, Akira Ooki, Tomoko Hiraoka, Kensei Yamaguchi, Takashi Yokokawa, Takeshi Aoyama, Kenichi Suzuki
Publikováno v:
Cancer Chemotherapy and Pharmacology. 87:767-777
The association between the pharmacokinetics and pharmacodynamics of regorafenib, a multiple tyrosine kinase inhibitor, remains unclear. This study assessed the trough plasma concentrations (Ctrough) of regorafenib and its N-oxide (M2) and N-oxide/de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1414a8d60a33ea5f0ecd45f3a5647e0a
https://doi.org/10.1007/s00280-021-04237-x
https://doi.org/10.1007/s00280-021-04237-x
Autor:
Hiroki Osumi, Eiji Shinozaki, Mitsukuni Suenaga, Takeru Wakatsuki, Izuma Nakayama, Tomohiro Matsushima, Mariko Ogura, Takashi Ichimura, Daisuke Takahari, Keisho Chin, Toshiya Nagasaki, Tsuyoshi Konishi, Takashi Akiyoshi, Yoshiya Fujimoto, Satoshi Nagayama, Yosuke Fukunaga, Masashi Ueno, Kensei Yamaguchi
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0176745 (2017)
There are robust data supporting the contribution of oxaliplatin (L-OHP) regarding clinical outcomes for colorectal cancer (CRC) in an adjuvant setting in European and US trials; however, there is no Japanese clinical evidence although L-OHP has been
Externí odkaz:
https://doaj.org/article/e2f3c30680e64d20a8ea75e85520bc89
Autor:
Tomohiro Matsushima, Mariko Ogura, Daisuke Takahari, Keisho Chin, Izuma Nakayama, Hiroki Osumi, Shoko Marshall, Takashi Ichimura, Takeru Wakatsuki, Kensei Yamaguchi, Naoki Ishizuka, Eiji Shinozaki
Publikováno v:
Journal of gastrointestinal cancer.
Background: Prognostic factors for the survival of patients with advanced HER2-positive gastric cancer treated with trastuzumab-based chemotherapy remain controversial. The aim of this study was to reveal the clinical factors that predict prognosis i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12fb4a98b71ee91bcad526c765dbea20
https://pubmed.ncbi.nlm.nih.gov/35435573
https://pubmed.ncbi.nlm.nih.gov/35435573
Autor:
Akira Ooki, Taroh Satoh, Kei Muro, Atsuo Takashima, Shigenori Kadowaki, Daisuke Sakai, Takashi Ichimura, Seiichiro Mitani, Toshihiro Kudo, Keisho Chin, Shigehisa Kitano, Dung Thai, Marianna Zavodovskaya, JieJane Liu, Narikazu Boku, Kensei Yamaguchi
Publikováno v:
Scientific reports. 12(1)
Andecaliximab (ADX) is a monoclonal antibody that inhibits matrix metalloproteinase 9 (MMP9), an extracellular enzyme involved in matrix remodeling, tumor growth, and metastasis. In preclinical models, MMP9 inhibitors have been shown to enhance the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfaafb18dfa4312330dbf78fdd981046
https://pubmed.ncbi.nlm.nih.gov/35773363
https://pubmed.ncbi.nlm.nih.gov/35773363
Autor:
Shinji Mine, Hiroki Osumi, Keisho Chin, Akihiko Okamura, Izuma Nakayama, Takashi Ichimura, Takao Asari, Kensei Yamaguchi, Takeshi Suzuki, Masayuki Watanabe, Mariko Ogura, Yu Imamura, Daisuke Takahari, Akira Ooki
Publikováno v:
Annals of Surgical Oncology. 27:1510-1517
The optimal treatment strategy for patients with borderline resectable (BR) esophageal squamous cell carcinoma (ESCC), in which tumors grow very close to the adjacent vital organs, remains unclear. This study evaluated the efficacy of neoadjuvant che
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9490265d9331fa816b364b2f5733eb37
https://doi.org/10.1245/s10434-019-08124-x
https://doi.org/10.1245/s10434-019-08124-x
Autor:
Mariko Ogura, Daisuke Takahari, Eiji Shinozaki, Takeru Wakatsuki, Akira Ooki, Hiroki Osumi, Keisho Chin, Mitsukuni Suenaga, Takeshi Suzuki, Izuma Nakayama, Yumiko Ota, Kensei Yamaguchi, Takashi Ichimura
Publikováno v:
Cancer Chemotherapy and Pharmacology. 84:307-313
Few data of folinic acid, fluorouracil, and irinotecan (FOLFIRI) plus ramucirumab (RAM) obtained in bevacizumab-naive patients in clinical trials or routine clinical practice are available. The purpose of this retrospective study was to report the re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a2e7a88b8df5b7b4e4677876eb950c0
https://doi.org/10.1007/s00280-019-03855-w
https://doi.org/10.1007/s00280-019-03855-w
Autor:
Yasumasa, Oomori, Yasufumi, Kawarada, Masataka, Isobe, Tomohiro, Ueno, Takashi, Ichimura, Shonosuke, MIZUNO, Yusuke, Okajima, Takashi, Higashihara, Ziye, Li, Sadato, Yamazaki
Publikováno v:
上越教育大学研究紀要 = Bulletin of Joetsu University of Education. 38(2):403-414
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::77b4c54ed82a86d9a88b6d777b85f0f2
http://hdl.handle.net/10513/00007968
http://hdl.handle.net/10513/00007968